Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Distal extremities soft tissue sarcomas: Are they so different from other limb localizations?

Mattei JC, Brouste V, Terrier P, Bonvalot S, Lecesne A, Stoeckle E, Italiano A, Ranchere-Vince D, Meeus P, Laé M, Rosset P, Rochwerger A, Coindre JM, Salas S.

J Surg Oncol. 2019 Jan 4. doi: 10.1002/jso.25359. [Epub ahead of print]

PMID:
30609044
2.

[Soft tissue sarcoma of the upper extremities. Analysis of factors relevant for prognosis in 160 patients].

Lehnhardt M, Hirche C, Daigeler A, Goertz O, Ring A, Hirsch T, Drücke D, Hauser J, Steinau HU.

Chirurg. 2012 Feb;83(2):143-52. doi: 10.1007/s00104-011-2124-6. German. Erratum in: Chirurg. 2012 May;83(5):485-6.

PMID:
21695557
3.

The pathologic response of resected synovial sarcomas to hyperthermic isolated limb perfusion with melphalan and TNF-α: a comparison with the whole group of resected soft tissue sarcomas.

Schwindenhammer B, Podleska LE, Kutritz A, Bauer S, Sheu SY, Taeger G, Schmid KW, Grabellus F.

World J Surg Oncol. 2013 Aug 12;11(1):185. doi: 10.1186/1477-7819-11-185.

4.

Postoperative Radiotherapy After Limb-sparing Surgery for Soft-tissue Sarcomas of the Distal Extremities.

Kim YJ, Song SY, Choi W, Je HU, Ahn JH, Chung HW, Lee JS.

Anticancer Res. 2016 Sep;36(9):4825-31.

PMID:
27630336
5.

The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy.

Rosenberg SA, Tepper J, Glatstein E, Costa J, Baker A, Brennan M, DeMoss EV, Seipp C, Sindelar WF, Sugarbaker P, Wesley R.

Ann Surg. 1982 Sep;196(3):305-15.

6.

Limb-sparing therapy of extremity soft tissue sarcomas: treatment outcome and long-term functional results.

Keus RB, Rutgers EJ, Ho GH, Gortzak E, Albus-Lutter CE, Hart AA.

Eur J Cancer. 1994;30A(10):1459-63.

PMID:
7833102
7.

High-grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality.

Eilber FC, Rosen G, Nelson SD, Selch M, Dorey F, Eckardt J, Eilber FR.

Ann Surg. 2003 Feb;237(2):218-26.

8.

Surgical considerations for management of distal extremity soft tissue sarcomas.

Ferguson PC.

Curr Opin Oncol. 2005 Jul;17(4):366-9. Review.

PMID:
15933470
9.

Management and outcome of acral soft-tissue sarcomas.

Dean BJF, Branford-White H, Giele H, Critchley P, Cogswell L, Athanasou N, Gibbons CLM.

Bone Joint J. 2018 Nov;100-B(11):1518-1523. doi: 10.1302/0301-620X.100B11.BJJ-2018-0301.R1.

PMID:
30418059
10.

Comparison of amputation with limb-sparing operations for adult soft tissue sarcoma of the extremity.

Williard WC, Hajdu SI, Casper ES, Brennan MF.

Ann Surg. 1992 Mar;215(3):269-75.

11.

Radiosensitivity translates into excellent local control in extremity myxoid liposarcoma: a comparison with other soft tissue sarcomas.

Chung PW, Deheshi BM, Ferguson PC, Wunder JS, Griffin AM, Catton CN, Bell RS, White LM, Kandel RA, O'Sullivan B.

Cancer. 2009 Jul 15;115(14):3254-61. doi: 10.1002/cncr.24375.

12.

Influence of surgical margins on outcome in patients with preoperatively irradiated extremity soft tissue sarcomas.

Tanabe KK, Pollock RE, Ellis LM, Murphy A, Sherman N, Romsdahl MM.

Cancer. 1994 Mar 15;73(6):1652-9.

PMID:
8156492
13.

Long-term results of tumor necrosis factor alpha- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas.

Deroose JP, Eggermont AM, van Geel AN, Burger JW, den Bakker MA, de Wilt JH, Verhoef C.

J Clin Oncol. 2011 Oct 20;29(30):4036-44. doi: 10.1200/JCO.2011.35.6618. Epub 2011 Sep 19.

PMID:
21931039
14.

Amputation for extremity soft tissue sarcoma does not increase overall survival: a retrospective cohort study.

Alamanda VK, Crosby SN, Archer KR, Song Y, Schwartz HS, Holt GE.

Eur J Surg Oncol. 2012 Dec;38(12):1178-83. doi: 10.1016/j.ejso.2012.08.024. Epub 2012 Sep 15.

PMID:
22985713
15.

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience.

Eggermont AM, Schraffordt Koops H, Klausner JM, Kroon BB, Schlag PM, Liénard D, van Geel AN, Hoekstra HJ, Meller I, Nieweg OE, Kettelhack C, Ben-Ari G, Pector JC, Lejeune FJ.

Ann Surg. 1996 Dec;224(6):756-64; discussion 764-5.

16.

Isolated limb perfusion for the management limb threatening soft tissue sarcomas: The role of histological type on clinical outcomes.

Rastrelli M, Mocellin S, Stramare R, Brunello A, Maruzzo M, Basso U, Scarzello G, Buzzaccarini MS, Pilati P, Saadeh LM, Del Fiore SP, Tosi A, Montesco C, Campana LG, Tropea S, Rossi CR.

Eur J Surg Oncol. 2017 Feb;43(2):401-406. doi: 10.1016/j.ejso.2016.09.021. Epub 2016 Nov 18.

PMID:
27890347
17.

[Results of isolated hyperthermic extremity perfusion in soft tissue sarcomas within the scope of a multimodality treatment concept].

Schwarzbach M, Lehnert T, Willeke F, Hinz U, Herfarth C.

Chirurg. 1996 Dec;67(12):1237-43. German.

PMID:
9081786
18.

Isolated limb perfusion with TNF-alpha and melphalan for distal parts of the limb in soft tissue sarcoma patients.

Deroose JP, van Geel AN, Burger JW, Eggermont AM, Verhoef C.

J Surg Oncol. 2012 May;105(6):563-9. doi: 10.1002/jso.22121. Epub 2011 Oct 21.

PMID:
22020863
19.

TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities.

Koelsche C, Renner M, Hartmann W, Brandt R, Lehner B, Waldburger N, Alldinger I, Schmitt T, Egerer G, Penzel R, Wardelmann E, Schirmacher P, von Deimling A, Mechtersheimer G.

J Exp Clin Cancer Res. 2014 Apr 11;33:33. doi: 10.1186/1756-9966-33-33.

20.

Hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan in advanced soft-tissue sarcomas: histopathological considerations.

Issakov J, Merimsky O, Gutman M, Kollender Y, Lev-Chelouche D, Abu-Abid S, Lifschitz-Mercer B, Inbar M, Klausner JM, Meller I.

Ann Surg Oncol. 2000 Mar;7(2):155-9.

PMID:
10761796

Supplemental Content

Support Center